Latest Breaking News On - First in class sarcomere modulator - Page 1 : comparemela.com

– Announced positive 12-month topline results from the ARCH open label study of EDG-5506 in adults with Becker muscular dystrophy – – Advancing Phase 2 trial of EDG-5506 in Becker muscular. -Today at 08:03 am- MarketScreener

United statesDuchenne beckerKevin kochDrug administrationResearch rowEdgewise therapeutics incSecurities exchangeExchange commissionEdgewise therapeuticsChief executive officerMonth topline resultsLabel studyFirst in class sarcomere modulatorMuscular dystrophy patientParent project muscular dystrophyAnnual conference